These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7949111)

  • 21. Detection of residual leukemia by the polymerase chain reaction and sequence-specific oligonucleotide probe hybridization after allogeneic bone marrow transplantation for AKR leukemia: a murine model for minimal residual disease.
    Drobyski WR; Baxter-Lowe LA; Truitt RL
    Blood; 1993 Jan; 81(2):551-9. PubMed ID: 8422472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells.
    Lemoli RM; Fortuna A; Motta MR; Rizzi S; Giudice V; Nannetti A; Martinelli G; Cavo M; Amabile M; Mangianti S; Fogli M; Conte R; Tura S
    Blood; 1996 Feb; 87(4):1625-34. PubMed ID: 8608257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
    Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
    Bone Marrow Transplant; 2000 Apr; 25(8):843-51. PubMed ID: 10808205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of the analysis of cellular chimerism following bone marrow graft by amplification of minisatellite sequences or specific of the Y chromosome].
    Lasfargues G; Landman Parker J; Blaise A; Brison O; Leverger G
    Bull Acad Natl Med; 1995 Feb; 179(2):357-65; discussion 365-6. PubMed ID: 7614063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.
    Jiang Z; Adams GB; Hanash AM; Scadden DT; Levy RB
    Biol Blood Marrow Transplant; 2002; 8(11):588-96. PubMed ID: 12463477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Third-party-mediated graft rejection and graft-versus-host disease after T-cell-depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism.
    Drobyski W; Thibodeau S; Truitt RL; Baxter-Lowe LA; Gorski J; Jenkins R; Gottschall J; Ash RC
    Blood; 1989 Nov; 74(6):2285-94. PubMed ID: 2572285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism.
    Wu CJ; Chillemi A; Alyea EP; Orsini E; Neuberg D; Soiffer RJ; Ritz J
    Blood; 2000 Jan; 95(1):352-9. PubMed ID: 10607724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers.
    Scharf SJ; Smith AG; Hansen JA; McFarland C; Erlich HA
    Blood; 1995 Apr; 85(7):1954-63. PubMed ID: 7703498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring and prognostic evaluation of sex-mismatched bone marrow transplantation by competitive PCR on Y chromosome sequences.
    Patri S; Dascalesu C; Chomel JC; Sadoun A; Lacotte L; Tanzer J; Guilhot F; Kitzis A
    Bone Marrow Transplant; 1996 Apr; 17(4):625-32. PubMed ID: 8722366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum.
    Aversa F; Tabilio A; Terenzi A; Velardi A; Falzetti F; Giannoni C; Iacucci R; Zei T; Martelli MP; Gambelunghe C
    Blood; 1994 Dec; 84(11):3948-55. PubMed ID: 7524753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune reconstitution in patients with Fanconi anemia after allogeneic bone marrow transplantation.
    Perlingeiro Beltrame M; Malvezzi M; Bonfim C; Covas DT; Orfao A; Pasquini R
    Cytotherapy; 2014 Jul; 16(7):976-89. PubMed ID: 24831839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning regimen, but it is not associated with an increased risk of relapse.
    van Leeuwen JE; van Tol MJ; Joosten AM; Wijnen JT; Verweij PJ; Khan PM; Vossen JM
    Blood; 1994 May; 83(10):3059-67. PubMed ID: 8180403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.
    Gadalla SM; Wang T; Dagnall C; Haagenson M; Spellman SR; Hicks B; Jones K; Katki HA; Lee SJ; Savage SA
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2276-2282. PubMed ID: 27641680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host origin of the human hematopoietic microenvironment following allogeneic bone marrow transplantation.
    Laver J; Jhanwar SC; O'Reilly RJ; Castro-Malaspina H
    Blood; 1987 Dec; 70(6):1966-8. PubMed ID: 3315046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of hematopoietic chimerism after allogeneic bone marrow transplantation by modern molecular techniques (STR-PCR and RQ-PCR)--single center].
    Czekalska S; Sacha T; Piatkowska-Jakubas B; Zawada M; Florek I; Cwynar D; Skotnicki AB
    Przegl Lek; 2010; 67(12):1282-91. PubMed ID: 21591354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.
    Gadalla SM; Wang T; Haagenson M; Spellman SR; Lee SJ; Williams KM; Wong JY; De Vivo I; Savage SA
    JAMA; 2015 Feb; 313(6):594-602. PubMed ID: 25668263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of the composition of the bone marrow graft on engraftment and graft-versus-host disease.
    Jansen J; Goselink HM; Veenhof WF; Zwaan FE; Blotkamp C
    Exp Hematol; 1983 Nov; 11(10):967-73. PubMed ID: 6363114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells.
    Jiang YZ; Kanfer EJ; Macdonald D; Cullis JO; Goldman JM; Barrett AJ
    Bone Marrow Transplant; 1991 Oct; 8(4):253-8. PubMed ID: 1756322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplantation of anergic histoincompatible bone marrow allografts.
    Guinan EC; Boussiotis VA; Neuberg D; Brennan LL; Hirano N; Nadler LM; Gribben JG
    N Engl J Med; 1999 Jun; 340(22):1704-14. PubMed ID: 10352162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term engraftment following in utero T cell-depleted parental marrow transplantation into fetal rhesus monkeys.
    Cowan MJ; Tarantal AF; Capper J; Harrison M; Garovoy M
    Bone Marrow Transplant; 1996 Jun; 17(6):1157-65. PubMed ID: 8807129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.